RA
TauC3 Biologics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Tau Immunotherapy | Tau-related Frontotemporal Dementia (FTD-tau) | Pre-clinical |
Leadership Team at TauC3 Biologics
BG
Bia Goncalves, PhD
Director of Scientific Communications
SP
Scott Pollack, PhD
Scientific Leader (implied)
PM
Peter McGowan
Chief Financial Officer
MP
Michael P. Ross, PhD, CFA
Board Member
SV
Shafique Virani, MD
Director
PS
Parag Saxena
Director
JS
John S. Gogol
Director
DG
Daniel G. Chain, PhD
Director/Scientific Founder